Your browser doesn't support javascript.
HIV skews the SARS-CoV-2 B cell response towards an extrafollicular maturation pathway.
Krause, Robert; Snyman, Jumari; Shi-Hsia, Hwa; Muema, Daniel; Karim, Farina; Ganga, Yashica; Ngoepe, Abigail; Zungu, Yenzekile; Gazy, Inbal; Bernstein, Mallory; Khan, Khadija; Mazibuko, Matilda; Mthabela, Ntombifuthi; Ramjit, Dirhona; Limbo, Oliver; Jardine, Joseph; Sok, Devin; Wilson, Ian A; Hanekom, Willem; Sigal, Alex; Kløverpris, Henrik; Ndung'u, Thumbi; Leslie, Alasdair.
  • Krause R; Africa Health Research Institute, Durban, South Africa.
  • Snyman J; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Shi-Hsia H; Africa Health Research Institute, Durban, South Africa.
  • Muema D; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Karim F; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu Natal, Durban, South Africa.
  • Ganga Y; Africa Health Research Institute, Durban, South Africa.
  • Ngoepe A; Division of Infection and Immunity, University College London, London, United Kingdom.
  • Zungu Y; Africa Health Research Institute, Durban, South Africa.
  • Gazy I; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Bernstein M; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu Natal, Durban, South Africa.
  • Khan K; Africa Health Research Institute, Durban, South Africa.
  • Mazibuko M; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Mthabela N; Africa Health Research Institute, Durban, South Africa.
  • Ramjit D; Africa Health Research Institute, Durban, South Africa.
  • Limbo O; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Jardine J; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Sok D; KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
  • Wilson IA; Africa Health Research Institute, Durban, South Africa.
  • Hanekom W; Africa Health Research Institute, Durban, South Africa.
  • Sigal A; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Kløverpris H; Africa Health Research Institute, Durban, South Africa.
  • Ndung'u T; Africa Health Research Institute, Durban, South Africa.
  • Leslie A; Africa Health Research Institute, Durban, South Africa.
Elife ; 112022 10 27.
Статья в английский | MEDLINE | ID: covidwho-2164143
ABSTRACT

Background:

HIV infection dysregulates the B cell compartment, affecting memory B cell formation and the antibody response to infection and vaccination. Understanding the B cell response to SARS-CoV-2 in people living with HIV (PLWH) may explain the increased morbidity, reduced vaccine efficacy, reduced clearance, and intra-host evolution of SARS-CoV-2 observed in some HIV-1 coinfections.

Methods:

We compared B cell responses to COVID-19 in PLWH and HIV negative (HIV-ve) patients in a cohort recruited in Durban, South Africa, during the first pandemic wave in July 2020 using detailed flow cytometry phenotyping of longitudinal samples with markers of B cell maturation, homing, and regulatory features.

Results:

This revealed a coordinated B cell response to COVID-19 that differed significantly between HIV-ve and PLWH. Memory B cells in PLWH displayed evidence of reduced germinal centre (GC) activity, homing capacity, and class-switching responses, with increased PD-L1 expression, and decreased Tfh frequency. This was mirrored by increased extrafollicular (EF) activity, with dynamic changes in activated double negative (DN2) and activated naïve B cells, which correlated with anti-RBD-titres in these individuals. An elevated SARS-CoV-2-specific EF response in PLWH was confirmed using viral spike and RBD bait proteins.

Conclusions:

Despite similar disease severity, these trends were highest in participants with uncontrolled HIV, implicating HIV in driving these changes. EF B cell responses are rapid but give rise to lower affinity antibodies, less durable long-term memory, and reduced capacity to adapt to new variants. Further work is needed to determine the long-term effects of HIV on SARS-CoV-2 immunity, particularly as new variants emerge.

Funding:

This work was supported by a grant from the Wellcome Trust to the Africa Health Research Institute (Wellcome Trust Strategic Core Award [grant number 201433/Z/16/Z]). Additional funding was received from the South African Department of Science and Innovation through the National Research Foundation (South African Research Chairs Initiative [grant number 64809]), and the Victor Daitz Foundation.
Тема - темы
ключевые слова

Полный текст: Имеется в наличии Коллекция: Международные базы данных база данных: MEDLINE Основная тема: HIV Infections / COVID-19 Тип исследования: Когортное исследование / Наблюдательное исследование / Прогностическое исследование Темы: Вакцина / Варианты Пределы темы: Люди Страна как тема: Африка Язык: английский Год: 2022 Тип: Статья Аффилированная страна: ELife.79924

Документы, близкие по теме

MEDLINE

...
LILACS

LIS


Полный текст: Имеется в наличии Коллекция: Международные базы данных база данных: MEDLINE Основная тема: HIV Infections / COVID-19 Тип исследования: Когортное исследование / Наблюдательное исследование / Прогностическое исследование Темы: Вакцина / Варианты Пределы темы: Люди Страна как тема: Африка Язык: английский Год: 2022 Тип: Статья Аффилированная страна: ELife.79924